FIELD: medicine.
SUBSTANCE: immediately after brain infusion, physiological solution is introduced intravenously, which contains activated macrophages in amount of 0.5-1·106. Then 3-4 days after injury the following preparations are injected successively - physiological solution containing mesenchymal stem cells in amount of 5-10·106 intravenously and physiological solution containing mesenchymal stem cells in amount of 4-5·106 intracutaneously.
EFFECT: minimisation of brain damage and restoration of brain tissue structure with elimination of treatment traumaticity.
1 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPY OF ARTHROSIS | 2007 |
|
RU2360691C1 |
METHOD OF PARALYSIS AND EPILEPSY TREATMENT IN DOGS | 2008 |
|
RU2371187C1 |
METHOD OF TREATING DOG'S CORNEAL, RETINAL AND OPTIC NERVE DISEASES | 2011 |
|
RU2481112C1 |
METHOD OF DOG ORGANISM BIOSTIMULATION | 2008 |
|
RU2371188C1 |
METHOD OF TREATING PATIENTS WITH COMBINED CRANIOCEREBRAL INJURY | 2010 |
|
RU2446834C2 |
METHOD OF TREATING PERIODONTITIS | 2010 |
|
RU2440060C1 |
METHOD OF TREATING POSTTRAUMATIC ENCEPHALOPATHY | 2009 |
|
RU2413523C2 |
METHOD FOR RECONSTRUCTING HYALINE ARTICULAR CARTILAGE | 2004 |
|
RU2268738C1 |
METHOD OF TREATING TEMPOROMANDIBULAR JOINT ARTHROSIS | 2010 |
|
RU2440062C1 |
METHOD FOR TREATING CRANIOCEREBRAL TRAUMA | 2002 |
|
RU2252023C2 |
Authors
Dates
2009-02-27—Published
2007-07-17—Filed